Drug-loaded microbubble delivery system to enhance PD-L1 blockade immunotherapy with remodeling immune microenvironment

被引：0
|
作者：
Jun Zheng
Ju Huang
Liang Zhang
Mengna Wang
Lihong Xu
Xiaoyun Dou
Xiaojing Leng
Mingxiao Fang
Yang Sun
Zhigang Wang
机构：
[1] The Second Affiliated Hospital,State Key Laboratory of Ultrasound in Medicine and Engineering, Institute of Ultrasound Imaging
[2] Chongqing Medical University,Ultrasound Department
[3] The First Affiliated Hospital of Chongqing Medical University,Department of Pathology, College of Basic Medicine
[4] Chongqing Medical University,Institute of Life Sciences
[5] Chongqing Medical University,undefined
来源：
Biomaterials Research | / 27卷
关键词：
Ultrasound-targeted microbubble destruction (UTMD); Immune checkpoint blockade (ICB); Docetaxel (DTX); PD-L1; Tumor immunosuppressive microenvironment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] PD-L1 and Emerging Biomarkers in Immune Checkpoint Blockade Therapy
    Cottrell, Tricia R.
    Taube, Janis M.
    CANCER JOURNAL, 2018, 24 (01): : 41 - 46
  • [42] Polymeric PD-L1 blockade nanoparticles for cancer photothermal-immunotherapy
    Yu, Yunjian
    Li, Jie
    Song, Boyi
    Ma, Zhuang
    Zhang, Yufei
    Sun, Haonan
    Wei, Xiaosong
    Bai, Yayun
    Lu, Xueguang
    Zhang, Peng
    Zhang, Xinge
    BIOMATERIALS, 2022, 280
  • [43] Polymeric PD-L1 blockade nanoparticles for cancer photothermal-immunotherapy
    Yu, Yunjian
    Li, Jie
    Song, Boyi
    Ma, Zhuang
    Zhang, Yufei
    Sun, Haonan
    Wei, Xiaosong
    Bai, Yayun
    Lu, Xueguang
    Zhang, Peng
    Zhang, Xinge
    Biomaterials, 2022, 280
  • [44] Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy
    Mayoux, Maud
    Roller, Andreas
    Pulko, Vesna
    Sammicheli, Stefano
    Chen, Stanford
    Sum, Eva
    Jost, Christian
    Fransen, Marieke F.
    Buser, Regula B.
    Kowanetz, Marcin
    Rommel, Karolin
    Matos, Ines
    Colombetti, Sara
    Belousov, Anton
    Karanikas, Vaios
    Ossendorp, Ferry
    Hegde, Priti S.
    Chen, Daniel S.
    Umana, Pablo
    Perro, Mario
    Klein, Christian
    Xu, Wei
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (534)
  • [45] Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy
    Escors, David
    Bocanegra, Ana
    Chocarro, Luisa
    Blanco, Ester
    Pineiro-Hermida, Sergio
    Garnica, Maider
    Fernandez-Rubio, Leticia
    Vera, Ruth
    Arasanz, Hugo
    Kochan, Grazyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [46] Recent Advancements in the Mechanisms Underlying Resistance to PD-1/PD-L1 Blockade Immunotherapy
    Yuan, Yu
    Adam, Abdalla
    Zhao, Chen
    Chen, Honglei
    CANCERS, 2021, 13 (04) : 1 - 18
  • [47] Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune Microenvironment
    Sun, Chengliang
    Yin, Mingxiao
    Cheng, Yao
    Kuang, Zean
    Liu, Xiaojia
    Wang, Gefei
    Wang, Xiao
    Yuan, Kai
    Min, Wenjian
    Dong, Jingwen
    Hou, Yi
    Hu, Lingrong
    Zhang, Guoyu
    Pei, Wenli
    Wang, Liping
    Sun, Yanze
    Yu, Xinmiao
    Xiao, Yibei
    Deng, Hongbin
    Yang, Peng
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (03) : 2064 - 2083
  • [48] Phytochemicals in regulating PD-1/PD-L1 and immune checkpoint blockade therapy
    Zhang, Qi
    Yang, Chenying
    Gao, Xingsu
    Dong, Ju
    Zhong, Caiyun
    PHYTOTHERAPY RESEARCH, 2024, 38 (02) : 776 - 796
  • [49] Predictive biomarkers for PD-1 and PD-L1 immune checkpoint blockade therapy
    Song, Yue
    Li, Zhaoming
    Xue, Weili
    Zhang, Mingzhi
    IMMUNOTHERAPY, 2019, 11 (06) : 515 - 529
  • [50] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
    Hartkopf, Andreas D.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Walter, Christina B.
    Kraemer, Bernhard
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2016, 11 (06) : 385 - 390
12345